FDA to review whether to allow more access to certain peptides
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
The FDA is set to review whether to allow more access to certain peptides. There are concerns about potential conflicts of interest and disagreements among FDA scientists regarding the expansion of peptide access. The review will involve an expert panel, but the outcome and specifics of the proposal are unclear.
Full coverage
1
The Washington Post·3d ago2
NPR·Jul 83
Endocrinology Advisor·Apr 234
Medical Xpress·Jul 15
NBC News·Jun 306
Drug Topics·Apr 247
Reuters·Apr 158
fda.gov·May 15